Mankind Pharma to constitute committee to evaluate ways to integrate BSV
Advertisement
New Delhi: Mankind Pharma has announced that the Board of Directors of the Company at its meeting has inter-alia, considered and approved the constitution of a ‘Structural Integration Committee’ to consider and evaluate various structural alternatives to integrate Bharat Serums and Vaccines Limited (“BSV”) into Mankind Pharma Limited’s (“Company”) eco system (“Proposed Structural Integration”).
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.